Ramsay Health Care (RMY) Stock Price & Analysis
RMY Stock Chart & Stats
- Day’s Range
- EUR 34.60 - EUR 34.60
- 52-Week Range
- EUR 17.10 - EUR 34.80
- Previous Close
- EUR 34.40
- Volume
- N/A
- Average Volume (3M)
- 9
- Market Cap
- EUR 8.04B
- Enterprise Value
- EUR 21.31B
- Total Cash (Recent Filing)
- EUR 729.90M
- Total Debt (Recent Filing)
- EUR 11.00B
- Price to Earnings (P/E)
- 40.9
- Beta
- 0.61
- Next Earnings
- Mar 03, 2027 (Est.)
- EPS Estimate
- 0.47
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 1.65%
Bulls Say, Bears Say
Bulls Say
Underlying Earnings Growth
Broad revenue and EBIT growth indicates continued demand for Ramsay’s hospital services and improving operating leverage. Sustained earnings expansion across the group can strengthen internal funding capacity and support investment in facilities and technology.
Australian Operating Momentum
Australia is the core operating engine, combining admission growth with improving margins. Planned theatres and cath labs, higher utilisation and technology-led productivity should expand capacity and support durable share gains in a large healthcare market.
Cash Generation And Liquidity
Strong cash generation and substantial liquidity provide funding for capacity expansion while reducing reliance on external capital. Leverage below management’s target range and solid interest cover also improve resilience against operating volatility and financing demands.
Bears Say
Leverage And Earnings Volatility
A highly leveraged balance sheet limits financial flexibility, particularly when profitability is uneven. Volatile earnings and shareholder returns make deleveraging less predictable and could constrain acquisitions, dividends or investment during weaker operating periods.
European And UK Funding Pressure
Funding and reimbursement constraints in Europe create a persistent drag on group performance. Losses, high regional leverage and weak UK public activity may require restructuring or capital support, limiting the benefit of stronger Australian operations.
Persistent Cost And Financing Pressures
Multi-year wage agreements and elevated financing costs can absorb a meaningful portion of revenue growth. These pressures may restrict margin expansion, especially where reimbursement rates or public tariffs cannot fully recover labour and funding inflation.
RMY FAQ
What was Ramsay Health Care’s price range in the past 12 months?
What is Ramsay Health Care’s market cap?
When is Ramsay Health Care’s upcoming earnings report date?
How were Ramsay Health Care’s earnings last quarter?
Is Ramsay Health Care overvalued?
Does Ramsay Health Care pay dividends?
What is Ramsay Health Care’s EPS estimate?
How many shares outstanding does Ramsay Health Care have?
What happened to Ramsay Health Care’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Ramsay Health Care?
What is the TipRanks Smart Score and how is it calculated?
Ramsay Health Care Stock Smart Score
Company Description
Ramsay Health Care
Ramsay Health Care Limited is a prominent healthcare provider that manages and possesses hospitals. The company delivers medical services to both publicly funded and privately insured individuals. It maintains a substantial international presence, operating roughly 532 facilities across the Asia Pacific region, the United Kingdom, France, and the Nordic nations. Founded in 1964, its corporate headquarters are situated in Sydney, Australia.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Natalie Davis
- Employees
- 91,400
- Website
- www.ramsayhealth.com
- Address
- Level 7, Tower B 7 Westbourne Street, St Leonards, NSW, 2065, AU
Ramsay Health Care (RMY) Earnings & Revenues
RMY Company Deck
RMY Earnings Call
Earnings Call SentimentPositive
The call presents strong operational and financial momentum driven by Australian transformation initiatives and Funding Group improvements — evidenced by double-digit underlying EBIT growth in Australia, broad regional EBIT growth, improved margins and cash generation, higher dividends, and successful cost and utilization measures. Offsetting these positives are notable challenges in Europe (Ramsay Santé funding headwinds and working capital/timing issues), restructure costs and demand weakness at Elysium, wage inflation pressures from multi-year EBAs, a remediation provision relating to a Fair Work decision, and increased interest costs. On balance the company demonstrates tangible progress on its strategic priorities and financial discipline while managing several region-specific headwinds.
View all DE:RMY earnings summariesRMY Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 16 | 2 | 4 |
| Technical Analysis | 4 | 2 | 4 |
| Moving Averages | 12 | 0 | 0 |
